Shutdown disrupts SNAP benefits for millions, prompting state and local responses to address food insecurity.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Shutdown disrupts SNAP benefits for millions, prompting state and local responses to address food insecurity.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.